Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
Stopped early · Phase 2
Conditions studied: Stage IV Breast Cancer
In brief
RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating women who have stage IV breast cancer that has not responded to previous therapy.
Key facts
- Study ID
- NCT00003454
- Run by
- Burzynski Research Institute
- People needed
- 19
- Starts
- 1996-03-18
- Expected to finish
- 2002-12-28
- Last updated by the study team
- 2017-09-28
Who can join
Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Burzynski Clinic — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.